Search
for
Sort by
Research 61–90 of 355
- When bugs and drugs conspire: driving acneiform skin toxicity
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Acneiform Dermatoses
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Skin manifestations associated with systemic diseases – Part I
- Index
- General Dermatology
- Demodex Folliculitis of the Scalp: Clinicopathological Study of an Uncommon Entity
- Acne and Systemic Disease
- Acne in children
- Dermatologic Adverse Events from Cancer Treatments
- Clinical pearls in dermatology 2013
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Hypertrichosis of the pinnae in a patient using panitumumab
- PRIDE syndrome with lumbosacral hypertrichosis
- P62: An increase in Breslow thickness: coronavirus or coincidence?
- Folliculitis
- Clinico-epidemiological and Mycological Aspects of Tinea Incognito in Iran: A 16-Year Study
- Acne in women
- COVID-19 infection leading to acute pustular dermatoses
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Disorders of the skin appendages
- Comparison between<i>Malassezia</i>Folliculitis and Non-<i>Malassezia</i>Folliculitis
- Preparation and Physicochemical Evaluation of Topical Cream Ivermectin 1% for Treatment of Rosacea
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- A review of diagnosis and treatment of acne in adult female patients
- Hormonal treatment of acne vulgaris: an update